XML 26 R32.htm IDEA: XBRL DOCUMENT v3.20.1
Share Capital, Warrants and Options (Details Narrative)
 3 Months Ended 12 Months Ended
Dec. 18, 2019
CAD ($)
$ / shares
shares
Dec. 09, 2019
CAD ($)
shares
Oct. 04, 2019
shares
Mar. 31, 2020
CAD ($)
EquityInstruments
Option
shares
$ / shares
Mar. 31, 2019
CAD ($)
shares
Dec. 31, 2019
CAD ($)
EquityInstruments
shares
Dec. 31, 2018
shares
Issue of Equity [Line items]              
Expected dividend yield       0.00%    
Risk-free interest rate       1.21%    
Expected volatility       121.55%    
Eligible exploration expenditures | $       $ 38,974,000   $ 38,633,000  
Reserve [Member]              
Issue of Equity [Line items]              
Transfer to deficit for expired options and warrants | $       $ 199,971    
Stock Option Plan [Member]              
Issue of Equity [Line items]              
Period of options granted       5 years      
Number of stock option granted | Option       6,650,000      
Stock options exercisable price per share | $ / shares       $ 0.16      
Expense from share-based payment transactions on grant of options | $       $ 884,247    
Maximum [Member]              
Issue of Equity [Line items]              
Percentage of beneficially owns, issued and outstanding       10.00%      
Period of options granted       10 years      
Sentient Executive GP IV Limited [Member]              
Issue of Equity [Line items]              
Beneficially owned of common shares in total           36,980,982  
Percentage of beneficially owns, issued and outstanding           41.70%  
Contemporary Amperex Technology Limited [Member]              
Issue of Equity [Line items]              
Beneficially owned of common shares in total           22,944,444  
Percentage of beneficially owns, issued and outstanding           25.87%  
Post-consolidation Basis [Member] | Stock Option Plan [Member]              
Issue of Equity [Line items]              
Number of stock option granted | EquityInstruments       6,650,000    
Post-consolidation Basis [Member] | Sentient Executive GP IV Limited [Member]              
Issue of Equity [Line items]              
Beneficially owned of common shares in total             36,980,982
Percentage of beneficially owns, issued and outstanding             46.93%
Post-consolidation Basis [Member] | Contemporary Amperex Technology Limited [Member]              
Issue of Equity [Line items]              
Beneficially owned of common shares in total             20,000,000
Percentage of beneficially owns, issued and outstanding             25.38%
Series 1 Convertible Preferred Shares [Member]              
Issue of Equity [Line items]              
Authorized capital       100,000,000      
Par value per share | $ / shares            
Common Stock [Member]              
Issue of Equity [Line items]              
Number of shares issued       88,690,791 78,792,860    
Number of shares outstanding       88,690,791 78,792,860    
Share capital | $       $ 89,006,000   $ 89,006,000  
Common Stock [Member] | Non Brokered Private Placement [Member]              
Issue of Equity [Line items]              
Number of units issued 7,373,265            
Price of unit issued | $ / shares $ 0.18            
Number of flow-through common shares 2,224,666            
Flow-through common shares price | $ / shares $ 0.18            
Total gross proceeds | $ $ 1,727,628            
Number of common shares in unit 1            
Exercise price of warrant | $ / shares $ 0.25            
Share issuance costs in cash | $ $ 343,639            
Fair value of warrants issued | $ 265,217            
Flow-through share premium paid | $ 88,987            
Share capital | $ 311,453            
Eligible exploration expenditures | $            
Common Stock [Member] | Non Brokered Private Placement [Member] | Agent's Warrants [Member]              
Issue of Equity [Line items]              
Fair value of warrants issued | $ $ 21,445            
Common Stock [Member] | Non Brokered Private Placement [Member] | Warrants [Member]              
Issue of Equity [Line items]              
Expected life 2 years            
Expected dividend yield 0.00%            
Risk-free interest rate 1.73%            
Expected volatility 147.26%            
Common Stock [Member] | Post-consolidation Basis [Member]              
Issue of Equity [Line items]              
Number of shares issued   300,000       88,690,791 78,792,850
Number of shares outstanding           88,690,791 78,792,850
Fair value of common shares issued | $   $ 51,000          
Common Stock [Member] | Non-adjusting Events After Reporting Period [Member]              
Issue of Equity [Line items]              
Number of shares issued     787,928,500        
Consolidation of share issued and outstanding description     The Company completed a share consolidation of the Company's issued and outstanding common shares whereby for every ten (10) pre-consolidation common shares issued and outstanding, one (1) post-consolidation common share exists without par value. Share capital outstanding prior to the share consolidation was 787,928,500 common shares and 78,792,860 on a post-consolidation basis.        
Common Stock [Member] | Non-adjusting Events After Reporting Period [Member] | Post-consolidation Basis [Member]              
Issue of Equity [Line items]              
Number of shares outstanding     78,792,850        
Series 1 Preferred Shares [Member] | Post-consolidation Basis [Member]              
Issue of Equity [Line items]              
Number of shares outstanding       590,931 590,931    
Preferred Stock [Member]              
Issue of Equity [Line items]              
Share capital | $       $ 591,000   $ 591,000  
Number of votes per share at meeting of holders of preference shares       1      
Period from date of issuance when shares become convertible       6 months      
Period of notice to convert shares       10 days      
Conversion value of share | $ / shares       $ 1      
Factor by which number of shares on conversion is calculated | $ / shares       $ 9.00